Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1994

Founded1994

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

109.52B

Market cap109.52B

Price-Earnings ratio

18.71

Price-Earnings ratio18.71

Dividend yield

3.92%

Dividend yield3.92%

Average volume

2.41M

Average volume2.41M

High today

$45.24

High today$45.24

Low today

$44.83

Low today$44.83

Open price

$45.00

Open price$45.00

Volume

2.43M

Volume2.43M

52 Week high

$52.68

52 Week high$52.68

52 Week low

$42.28

52 Week low$42.28

SNY News

TipRanks 2d

OWKIN Deepens Sanofi Collaboration With Multi-Year AI-Driven Biopharma Partnership - TipRanks

...

TipRanks 2d

Sanofi and Kymera Advance SAR447971 Into First-in-Human Trial, Setting Up New Optionality in Inflammatory Skin Disease

Kymera Therapeutics, Inc. (KYMR), Sanofi SA (SNY) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRank...

TipRanks 2d

Novavax and Sanofi Advance Omicron JN.1 Booster With Completed Phase 3 Study

Novavax (NVAX) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and...

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

More SNY News

Benzinga 2d

Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative

The agreement also includes a five-year license for Owkin's AI Scientist platform, K Pro, marking the latest phase in a relationship that began in 2021. Partne...

TipRanks 3d

RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge

Regeneron Pharmaceuticals (REGN), Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks...

TipRanks 5d

Snowflake says Sanofi selects Snowflake Cortex AI for drug development

Snowflake (SNOW) announced at Snowflake Summit 26 that Sanofi (SNY) has established a new blueprint for AI-powered biopharma with its launch of “Concierge for F...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.